$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
5 Biotech Stocks That Generated 1,000%+ Returns In 2020
10:30am, Saturday, 26'th Dec 2020
The biopharma sector weathered the COVID-19 pandemic fairly well, with the Shares Nasdaq Biotechnology Etf (NASDAQ: IBB) outperforming the S&P 500 Index. This defensive sector also benefited from oppo
6 Biotech/Drug Stocks Up Manifold in 2020 Thanks to COVID-19
11:18am, Thursday, 24'th Dec 2020
We discuss six biotech/drug stocks, NVAX, VXRT, MRNA, TBIO, INO and BNTX that have more than doubled in 2020 on the back of their progress in coronavirus vaccine development.
These 5 Small-Cap Healthcare Stocks Gained the Most in 2020
06:55am, Wednesday, 23'rd Dec 2020
These stocks have made investors richer by posting explosive revenue growth or advancing significantly in high-impact programs.
Is There Still Room for Growth for These 2 Coronavirus Stocks?
06:48am, Tuesday, 22'nd Dec 2020
They are at a critical point. What happens next could push them higher, or result in a big loss.
4 Small COVID-19 Vaccine Makers to Look Out for in 2021
08:17am, Friday, 18'th Dec 2020
Here we discuss four small biotech companies, NVAX, CVAC, VXRT and ARCT, that are making COVID-19 vaccine candidates, which may be approved in 2021, if successfully developed, and bring profits.
3 Healthcare Stocks to Sell Before 2021
07:03am, Thursday, 17'th Dec 2020
It's been a great ride for these three in 2020, but there are clouds on the horizon.
3 COVID-19 Vaccine Stocks That Could Be the Biggest Winners in a Post-Pandemic World
06:14am, Wednesday, 16'th Dec 2020
They each have a key competitive edge that could set them apart.
These Were the 10 Best Healthcare Stocks of 2020
06:35am, Tuesday, 15'th Dec 2020
The highest performers of the year are biotechs fighting COVID-19 and cancer. Are they still buys for 2021?
COVID Vaccine Stock Ideas for Different Investors
10:35am, Sunday, 13'th Dec 2020
Whether you're aggressive, risk-averse, or somewhere in between, here are some coronavirus vaccine stocks you might want to consider.
Up Almost 2,000% in 2020, Is Vaxart Still a Buy?
12:04pm, Thursday, 10'th Dec 2020
A COVID-19 vaccine in tablet form would be a game-changer in the fight against the pandemic.
Did You Miss Out on a 2,000% Gain with Vaxart Stock?
11:50am, Wednesday, 09'th Dec 2020
If data from upcoming human trials for Vaxart's vaccine candidate are positive, you might have a second chance.
3 Top Coronavirus Stocks to Watch in December
06:20am, Friday, 04'th Dec 2020
Vaccine makers of all sizes and development stages face crucial news this month.
2 Ultra-Risky Coronavirus Stocks That Could Make You Filthy Rich
06:45am, Tuesday, 01'st Dec 2020
They'll be later to market than rivals. But if their product candidates are stronger, investors may reap rewards.
3 COVID Vaccine Stocks That Could Be Millionaire-Makers
06:08am, Sunday, 29'th Nov 2020
Here's what makes these coronavirus-focused biotechs stand out.
4 Biotechs Likely to Gain on Coronavirus Vaccine Efforts
09:11am, Friday, 27'th Nov 2020
In the race to develop a coronavirus vaccine, Pfizer and its partner BioNTech have a lead, closely followed by Moderna. However, four other biotechs, NVAX, TBIO, INO and VXRT, still hold potential to
Sign In
Buy VXRT